Cindy Weinstein, MD, PhD

Merck & Co, Inc
Rahway, NJ, United States

Dr. Cindy Weinstein has over 20 years of clinical research experience in respiratory and immunology diseases. She currently works in Global Clinical Development at Merck and serves as the Senior Clinical Director for the TNF inhibitor programs.

Disclosure information not submitted.

Presentation(s):

• 0545: Continuing (Full or Reduced Treatment) versus Withdrawing from Golimumab Treatment in Patients with Non-radiographic Spondylarthritis Who Achieved Inactive Disease: Efficacy and Safety Results from a Placebo-Controlled, Randomized Withdrawal and Retreatment Study (GO-BACK)

  Saturday, November 12, 2022
  5:15 PM – 5:25 PM Eastern Time